Tests of fibrin metabolism in recurrent venous thromboembolism

Publisher Website
Google Scholar
Abstract
Fibrinogen/fibrin degradation products (FDP/fdp) and soluble fibrin complexes (SFC) were measured serially in 60 patients heparinized for pulmonary embolism or deep venous thrombosis. Patients (8) had recurrent thromboembolism. In patients without recurrence, FDP/fdp and SFC tended to normalize within 3-5 days. In patients with recurrence, results of both tests were significantly higher on admission, and FDP/fdp values were significantly higher throughout 10 days of therapy, than in patients without recurrence. The SFC values were not different between the 2 groups during the first 6 days of treatment, but again became significantly higher on the 7th day in patients with recurrence. There were no differences in clotting times, heparin dosage or any other clinical features between patients with and without recurrence. Measurement of FDP/fdp and SFC can help identify patients at risk of recurrent thromboembolism if performed serially during treatment.